Location: Taiwan, Taiwan Province, Zhubei City
Employees: 51-200
Total raised: $80.6M
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | Biomark Ca... | biomarkcap... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.05.2015 | Series C | $45.6M | - |
| 20.06.2014 | Series B | $35M | - |
Mentions in press and media 9
| Date | Title | Description |
| 26.02.2020 | JHL Biotech Focuses on CDMO and Biologics Development for Global Markets After Spinoff | HSINCHU, Taiwan, February 26, 2020 — With a globally-focused enthusiasm and aspiration to build sustainable and reputable CDMO facilities for the China Biologics Market, JHL Biotech has made a strategic decision benefitting all of its patie... |
| 16.08.2019 | JHL Focusing on New Biosimilar Pipeline and Global Expansion of CDMO Business | HSINCHU, Taiwan and WUHAN, China, August 16, 2019 — JHL Biotech has reached a settlement agreement with Genentech to resolve Genentech’s civil claims related to the development of certain biologic therapies, or “biosimilar” medicines. After... |
| 02.10.2018 | JHL Biotech Raises Pre-IPO Funding at $750 Million Valuation JHL Biotech Raises Pre-IPO Funding at $750 Million Valuation | - |
| 13.05.2015 | JHL Biotech Successfully Raises $45.6 Million Series C Financing | HSINCHU, TAIWAN – May 11, 2015 – JHL Biotech, Inc., an emerging biopharmaceutical company, today announced that it has closed a Series C fundraising of $45.6 million, led by funds managed by a global renowned crossover fund with over US$1.6... |
| 12.05.2015 | JHL Biotech Closes $45.6M Series C Funding | JHL Biotech, Inc., a Hsinchu, China-based biopharmaceutical company, closed a $45.6m Series C funding. The round was led by funds managed by a global crossover fund, with participation from existing investor Milestone Capital and new invest... |
| 20.06.2014 | JHL Biotech Closes $35M Series B Financing | JHL Biotech, Inc., a Taiwan-based biopharmaceutical company, closed a $35m Series B financing round. The round was led by new investors Milestone Capital and a consortium of Taiwan venture capitalists and individuals, including President In... |
| 20.06.2014 | JHL Biotech Closes $35M Series B | HSINCHU, TAIWAN, Emerging biopharmaceutical company, today announced that it has closed a Series B financing round of $35 million. >> Click here for more funding data on JHL Biotech >> To export JHL Biotech funding data to P... |
| 06.12.2013 | JHL Biotech and Selexis SA Form Biologic Drug Development Alliance | |
| 25.09.2013 | GE Healthcare Life Sciences to Build KUBio Modular Biopharmaceutical Factory for JHL Biotech in China | New factory to give JHL Biotech commercial biopharmaceutical manufacturing capabilities in Asia |